Standard first-line chemotherapy for endometrial cancer is paclitaxel plus carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear. In this double-blind, placebo-controlled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback